Clinical Trials Office (CTO)

Advancing Innovation and Health Equity Through Quality Clinical Trials

The University of Alberta's Clinical Trials Office (CTO) serves as the secretariat for University of Alberta Clinical Trials (UACT), dedicated to advancing health outcomes through innovative and inclusive clinical research. Emphasizing collaboration and the meaningful inclusion of historically excluded populations, the CTO supports a diverse range of clinical trials with a focus on reliability, adaptability, efficiency, and innovation.

For Investigators

Investigators, Clinical Trialists, Clinician Scientists, Study Coordinators, Graduate Students

Investigator Supports

For Sponsors

Industry Partners, Pharmaceutical / Device Manufacturers, Contract Research Organizations

Sponsor Supports

For Community

Community Members, Study Participants, People with Lived Experience, Advocacy Groups

Community Supports

Learn more about our mission to foster excellence in clinical trials, the values that guide us, and the team that is here to support you.

Who We Are

The Clinical Trials Office (CTO) is your home for the latest news and events in clinical trials at the University of Alberta, and beyond.

News & Events

Key Initiatives and Units

Indigenous Clinical Trials Unit (ICTU)

As the first of its kind in Canada, the ICTU empowers Indigenous-led clinical research, addressing the unique health needs of Indigenous communities and promoting sovereignty and self-determination in health research and clinical trials.

Learn More About the ICTU

Digital Health Unit (DHU)

The Digital Health Unit, within the Clinical Trials Office, focuses on the use of digital technologies such as mobile apps, wearable devices, AI, and telemedicine to improve healthcare outcomes and make clinical trials more accessible.

Learn More About the DHU

Addressing Injustices in Clinical Trials

The CTO commits to rectifying inequities in trials by ensuring research is conducted with fairness, dignity, and respect for all communities, including Indigenous, racialized, 2SLGBTQIA+ populations, and individuals with disabilities.

Learn More About ACB in Clinical Trials

Clinical Trials Office (CTO)

Advancing Innovation and Health Equity Through Quality Clinical Trials

For Investigators

For Sponsors

For Community

Contact Us

CTO Connect Newsletter

Key Initiatives and Units

Indigenous Clinical Trials Unit (ICTU)

As the first of its kind in Canada, the ICTU empowers Indigenous-led clinical research, addressing the unique health needs of Indigenous communities and promoting sovereignty and self-determination in health research and clinical trials.

Digital Health Unit (DHU)

The Digital Health Unit, within the Clinical Trials Office, focuses on the use of digital technologies such as mobile apps, wearable devices, AI, and telemedicine to improve healthcare outcomes and make clinical trials more accessible.

Addressing Injustices in Clinical Trials

The CTO commits to rectifying inequities in trials by ensuring research is conducted with fairness, dignity, and respect for all communities, including Indigenous, racialized, 2SLGBTQIA+ populations, and individuals with disabilities.

Education

Services

Faculties

Clinical Trials Office (CTO)

Advancing Innovation and Health Equity Through Quality Clinical Trials

For Investigators

For Sponsors

For Community

Contact Us

CTO Connect Newsletter

Key Initiatives and Units

Indigenous Clinical Trials Unit (ICTU)

As the first of its kind in Canada, the ICTU empowers Indigenous-led clinical research, addressing the unique health needs of Indigenous communities and promoting sovereignty and self-determination in health research and clinical trials.

Digital Health Unit (DHU)

The Digital Health Unit, within the Clinical Trials Office, focuses on the use of digital technologies such as mobile apps, wearable devices, AI, and telemedicine to improve healthcare outcomes and make clinical trials more accessible.

Addressing Injustices in Clinical Trials

The CTO commits to rectifying inequities in trials by ensuring research is conducted with fairness, dignity, and respect for all communities, including Indigenous, racialized, 2SLGBTQIA+ populations, and individuals with disabilities.